OS Therapies Incorporated (OSTX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for OS Therapies Incorporated (OSTX).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $1.71

Daily Change: -$0.04 / 2.34%

Daily Range: $1.68 - $1.78

Market Cap: $58,797,512

Daily Volume: 416,099

Performance Metrics

1 Week: -1.14%

1 Month: 3.59%

3 Months: -12.18%

6 Months: -10.82%

1 Year: -48.28%

YTD: -59.58%

Company Details

Employees: 4

Sector: Health technology

Industry: Biotechnology

Country:

Details

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.

Selected stocks

Geron Corporation (GERN)

Getty Images Holdings, Inc. (GETY)

The Glimpse Group, Inc. (VRAR)